Literature DB >> 2882432

An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease.

J A Hardy, D M Mann, P Wester, B Winblad.   

Abstract

Observations, in Alzheimer's disease, in the pattern of nerve cell damage and loss, the pathology, microchemistry and immunology of senile plaques and neurofibrillary tangles and alterations in blood vessels are drawn together into a hypothesis that attempts to explain the pathogenesis and progression of the disorder. At the heart of this hypothesis lies a defect in blood brain barrier function and/or structure within the cerebral cortex and this defect may be the cause of the cerebral vessel amyloidosis common in many patients with Alzheimer's disease. Age-related alterations in blood brain barrier allow for damage to nerve terminals and limited formation of senile plaques within cerebral cortex; neurofibrillary tangles are formed within cortical and subcortical nerve cells which project to or near damaged vessels/senile plaques. Uptake of "neurotoxin" at affected terminals and retrograde transport to perikarya causes neurofibrillary tangles to be formed; their accumulation leads to perikaryal changes culminating in cell death and loss. Loss of cells in cortically projecting areas of subcortex such as nucleus basalis, locus caeruleus and dorsal raphe, which terminate on cerebral vessels, causes further blood brain barrier dysfunction, new plaque formation and continued cell loss in cortex and subcortex. Once started, such a process could be self-perpetuating and the initial site of damage could lie within the amygdala/hippocampus with putative pathogenic agent accessing the brain via the olfactory pathways.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2882432     DOI: 10.1016/0197-4580(86)90086-2

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  41 in total

Review 1.  Is Alzheimer's disease amyloidosis the result of a repair mechanism gone astray?

Authors:  Tyler A Kokjohn; Chera L Maarouf; Alex E Roher
Journal:  Alzheimers Dement       Date:  2011-11-02       Impact factor: 21.566

Review 2.  Neuronal AChE splice variants and their non-hydrolytic functions: redefining a target of AChE inhibitors?

Authors:  M Zimmermann
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

3.  Brainstem morphological changes in Alzheimer's disease.

Authors:  Ji Han Lee; John Ryan; Carmen Andreescu; Howard Aizenstein; Hyun Kook Lim
Journal:  Neuroreport       Date:  2015-05-06       Impact factor: 1.837

4.  Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease.

Authors:  S L Wagner; J W Geddes; C W Cotman; A L Lau; D Gurwitz; P J Isackson; D D Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Critical comments on "Propionibacterium acnes in the cortex of patients with Alzheimer's disease" by H.H. Kornhuber (Eur Arch Psychiatry Clin Neurosci, 1996, 246:108-109)

Authors:  J Bauer; G G Gottfries; H Förstl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 6.  Transcranial magnetic stimulation in Alzheimer's disease: a neurophysiological marker of cortical hyperexcitability.

Authors:  Giovanni Pennisi; Raffaele Ferri; Giuseppe Lanza; Mariagiovanna Cantone; Manuela Pennisi; Valentina Puglisi; Giulia Malaguarnera; Rita Bella
Journal:  J Neural Transm (Vienna)       Date:  2011-01-05       Impact factor: 3.575

7.  Adrenergic, serotoninergic, histaminergic, and imipramine binding sites in post-mortal human cerebral microvessel preparations.

Authors:  C O'Neill; C J Fowler; J O Marcusson; B Winblad
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

8.  The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures.

Authors:  A R White; G Multhaup; F Maher; S Bellingham; J Camakaris; H Zheng; A I Bush; K Beyreuther; C L Masters; R Cappai
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

9.  Amyloid-beta induces chemokine secretion and monocyte migration across a human blood--brain barrier model.

Authors:  M Fiala; L Zhang; X Gan; B Sherry; D Taub; M C Graves; S Hama; D Way; M Weinand; M Witte; D Lorton; Y M Kuo; A E Roher
Journal:  Mol Med       Date:  1998-07       Impact factor: 6.354

Review 10.  Hypertension and dementia.

Authors:  Olivier Hanon; Marie Laure Seux; Hermine Lenoir; Anne Sophie Rigaud; Françoise Forette
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.